In search of the optimal setting for statin trials in prostate cancer: the power of population-based studies.
作者信息
Allott Emma H, Craig Emma L, Stopsack Konrad H
机构信息
Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, UK.
Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
出版信息
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):583-584. doi: 10.1038/s41391-021-00355-y. Epub 2021 Mar 29.
Abstract
摘要
相似文献
1
In search of the optimal setting for statin trials in prostate cancer: the power of population-based studies.寻找前列腺癌他汀类药物试验的最佳设置：基于人群研究的作用
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):583-584. doi: 10.1038/s41391-021-00355-y. Epub 2021 Mar 29.
2
Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer.关于他汀类药物预防晚期前列腺癌的流行病学思考。
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2175-80. doi: 10.1158/1055-9965.EPI-07-0777. Epub 2007 Nov 2.
3
How statins may increase prostate cancer.他汀类药物如何可能增加前列腺癌风险。
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):459. doi: 10.1158/1055-9965.EPI-07-2776.
4
Statins: protectors or pretenders in prostate cancer?他汀类药物：在前列腺癌中是保护者还是伪装者？
Trends Endocrinol Metab. 2014 Apr;25(4):188-96. doi: 10.1016/j.tem.2013.12.007. Epub 2014 Jan 22.
5
Statin use and risk of prostate cancer in a population of men who underwent biopsy.他汀类药物的使用与接受前列腺活检男性的前列腺癌风险。
J Urol. 2011 Jul;186(1):86-90. doi: 10.1016/j.juro.2011.03.004. Epub 2011 May 14.
6
Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.他汀类药物的使用与前列腺癌生存：芬兰前列腺癌筛查随机研究。
Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.
7
Bias related to funding source in statin trials.他汀类药物试验中与资金来源相关的偏倚。
BMJ. 2014 Oct 3;349:g5949. doi: 10.1136/bmj.g5949.
8
No evidence of industry sponsorship bias in statin trials.
BMJ. 2014 Nov 4;349:g6579. doi: 10.1136/bmj.g6579.
9
Progress in Understanding What Is Being Statin(ed) in Prostate Cancer.前列腺癌中他汀类药物作用机制的认识进展
JAMA Oncol. 2015 Jul;1(4):428-30. doi: 10.1001/jamaoncol.2015.0833.
10
Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy.在接受放疗的高危局限性前列腺癌患者中，使用他汀类药物可改善生化结局。
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):713-8. doi: 10.1016/j.ijrobp.2009.12.006. Epub 2010 May 6.
引用本文的文献
1
Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers.高危基因突变携带者前列腺癌的临床管理
Cancers (Basel). 2022 Feb 16;14(4):1004. doi: 10.3390/cancers14041004.
Zotero 插件